AIFM1 Gene Deafness X-linked type 5 Genetic Test
Test Name: AIFM1 Gene Deafness X-linked type 5 Genetic Test
Components: Blood Sample
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Ear Nose Throat Disorders
Doctor: ENT Doctor
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A14
Test Details
AIFM1 gene deafness, X-linked type 5 NGS genetic test is a diagnostic test that uses Next-Generation Sequencing (NGS) technology to identify mutations in the AIFM1 gene associated with X-linked deafness type 5. X-linked deafness type 5 is a rare genetic disorder characterized by progressive hearing loss that predominantly affects males. Mutations in the AIFM1 gene, located on the X chromosome, are responsible for this condition.
NGS technology allows for the simultaneous sequencing of multiple genes, including the AIFM1 gene, in a single test. This enables the identification of specific mutations or variants that may be responsible for the individual’s hearing loss. The AIFM1 gene provides instructions for producing a protein called apoptosis-inducing factor, mitochondria-associated 1 (AIFM1). This protein plays a crucial role in the maintenance and function of mitochondria, which are responsible for producing energy in cells.
Mutations in the AIFM1 gene can disrupt the normal function of mitochondria, leading to the degeneration of sensory cells in the inner ear and resulting in hearing loss. The NGS genetic test for AIFM1 gene deafness, X-linked type 5 involves obtaining a DNA sample, typically through a blood sample or saliva sample. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variants in the AIFM1 gene.
The test results can help confirm a diagnosis of X-linked deafness type 5 and provide valuable information for genetic counseling and family planning. It can also assist in the development of personalized treatment plans and management strategies for individuals with this condition.
| Test Name | AIFM1 Gene Deafness X-linked type 5 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A14 |
| Test Details | AIFM1 gene deafness, X-linked type 5 NGS genetic test is a diagnostic test that uses Next-Generation Sequencing (NGS) technology to identify mutations in the AIFM1 gene associated with X-linked deafness type 5. X-linked deafness type 5 is a rare genetic disorder characterized by progressive hearing loss that predominantly affects males. Mutations in the AIFM1 gene, located on the X chromosome, are responsible for this condition. NGS technology allows for the simultaneous sequencing of multiple genes, including the AIFM1 gene, in a single test. This enables the identification of specific mutations or variants that may be responsible for the individual’s hearing loss. The AIFM1 gene provides instructions for producing a protein called apoptosis-inducing factor, mitochondria-associated 1 (AIFM1). This protein plays a crucial role in the maintenance and function of mitochondria, which are responsible for producing energy in cells. Mutations in the AIFM1 gene can disrupt the normal function of mitochondria, leading to the degeneration of sensory cells in the inner ear and resulting in hearing loss. The NGS genetic test for AIFM1 gene deafness, X-linked type 5 involves obtaining a DNA sample, typically through a blood sample or saliva sample. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variants in the AIFM1 gene. The test results can help confirm a diagnosis of X-linked deafness type 5 and provide valuable information for genetic counseling and family planning. It can also assist in the development of personalized treatment plans and management strategies for individuals with this condition. |
